Ryscor Science Inc. develops novel small-molecule synthetic reagents and methodologies for pharmaceutical and biotechnology companies worldwide. The company's technology is focused on biologically-biased multifunctional boronic acids and heterocyles used in diverse and target-oriented synthesis. These compounds enable researchers involved in drug discovery rapid and reliable access to target molecules.